CTOs on the Move

Portola

www.portola.com

 
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.portola.com
  • 270 E. Grand Avenue
    South San Francisco, CA USA 94080
  • Phone: 650.246.7000

Executives

Name Title Contact Details

Similar Companies

North American Health Care

North American Health Care, Inc. is a Dana Point, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SynteractHCR

SynteractHCR is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development.

Southwest Center

Southwest Center is a leader in providing HIV/AIDS services in Phoenix, AZ, including: HIV and STD testing, LGBTQ-friendly medical care, PrEP & PEP, community outreach, case management, behavioral health, empowerment programs, nutrition servic...

ClinAudits

ClinAudits is a Kinnelon, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Behaviorial Health Link

Behaviorial Health Link is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.